Quotes Abbott Laboratories Deutsche Boerse AG
Stocks
ABL0
CA0028221046
Medical Equipment, Supplies & Distribution
|
Delayed
Deutsche Boerse AG
10:50:13 07/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 10.70 EUR | -1.83% |
|
-1.83% | -20.15% |
| 04:14pm | Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target | MT |
| 10-05 | Abbott Laboratories Receives FDA Approval for New CardioMEMS HF System capabilities | CI |
Stock exchange
Deutsche Boerse AG
ABL0 10.70 €
-1.83%
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ABT | 98.16USD | -1.94% | 1.04B $ | ||
CBOE
| ABT | 98.17USD | -1.96% | 21.59M $ | |
|
London S.E.
| ABT | 100.56USD | +2.78% | 778K $ | |
|
Tradegate
| ABL | 87.64EUR | +0.50% | 95.97K € | |
|
CBOE
| ABT | 88.24EUR | +0.43% | 29.74K € | |
|
Boerse Muenchen
| ABL | 88.31EUR | +1.08% | 21.9K € | |
|
Borsa Italiana
| 1ABT | 85.98EUR | -0.62% | 12.9K € | |
|
Deutsche Boerse AG
| ABL | 87.00EUR | -2.23% | 11.14K € | |
|
Xetra
| ABL | 87.92EUR | -0.29% | 8.7K € | |
|
CBOE
| 88.36EUR | -1.21% | 4.59K € | ||
|
Mexican S.E.
| ABT * | 1,766.00MXN | -3.68% | 19.43K $ | |
|
Kazakhstan S.E.
| ABT_KZ | 110.00USD | 0.00% | 110 $ | |
|
Lima
| ABTUS | 100.98USD | 0.00% | 0 $ | |
|
Wiener Boerse
| ABT | 88.18EUR | -1.19% | 0 € | |
|
Swiss Exchange
| ABT | 83.00CHF | +3.11% | 0 CHF | |
|
Santiago S.E.
| ABTCL | 97,823.00CLP | -0.10% | 0 $ | |
|
Börse Stuttgart
| ABL | 87.68EUR | +0.60% | 0 € | |
|
Santiago S.E.
| ABT | 100.98USD | 0.00% | 0 $ | |
| ABTT34 | 40.76BRL | -2.67% | 23.97K R$ | ||
| ABT | 39,500.00ARS | -1.89% | 51.82M $ | ||
|
Buenos Aires S.E.
| ABTD | 25.68USD | -2.47% | 7.83K $ | |
| ABL0 | 10.70EUR | -1.83% | 0 € | ||
|
Toronto S.E.
| ABT | 17.16CAD | -1.89% | 470K $ |
Quotes 5-day view: Abbott Laboratories
Delayed Quote Deutsche Boerse AG
| 01/10/2026 | 02/10/2026 | 05/10/2026 | 06/10/2026 | 07/10/2026 | |
|---|---|---|---|---|---|
| Last | €10.70 | €10.70 | €10.60 | €10.90 | €10.70 |
| Change | -1.83% | 0.00% | -0.93% | +2.83% | -1.83% |
Performance
| 1 day | -1.83% | ||
| 1 week | -1.83% | ||
| Current month | -1.83% | ||
| 1 month | -9.32% | ||
| 3 months | +3.88% | ||
| 6 months | -5.31% | ||
| Current year | -20.15% | ||
| 1 year | -26.21% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
169,854,424,335
Market Cap (USD)
169,854,424,335
Net sales (USD)
44,328,000,000
Number of employees
115,000
Sales / Employee (USD)
385,461
Free-Float
86.16%
Free-Float capitalization (EUR)
190,385,568,624
Free-Float capitalization (USD)
169,005,269,267
Indicators
Moving average 5 days
10.76
Moving average 20 days
11.09
Moving average 50 days
11.57
Moving average 100 days
10.77
Price spread / (MMA5)
+0.56%
Price spread / (MMA20)
+3.64%
Price spread / (MMA50)
+8.15%
Price spread / (MMA100)
+0.67%
RSI 9 days
21.47
RSI 14 days
30.09
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.83% | -1.83% | -26.21% | - | 170B | |
| -1.94% | -2.76% | -26.60% | +1.32% | 170B | |
| -1.00% | 0.00% | -11.52% | +14.41% | 111B | |
| -2.46% | -0.20% | -24.05% | +4.65% | 107B | |
| -0.41% | +0.34% | -47.14% | -10.53% | 75.95B | |
| +0.46% | +2.85% | +3.63% | +72.08% | 60.37B | |
| -0.65% | +6.59% | +11.44% | +66.40% | 53.53B | |
| -0.20% | -0.92% | -6.09% | -31.29% | 49.11B | |
| -2.21% | -3.38% | -17.90% | +15.57% | 40.6B | |
| -4.04% | -3.75% | +25.66% | +0.20% | 31.47B | |
| Average | -0.89% | +0.25% | -11.88% | +14.76% | 86.89B | |
| Weighted average by Cap. | -0.74% | -0.04% | -18.17% | +12.21% |
Historical Quotes: Abbott Laboratories
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 10.6 |  | 10.9 |
| 1 month | 10.6 | | 11.8 |
| Current year | 9.2 | | 14.8 |
| 1 year | 9.2 | | 14.8 |
| 3 years | 9.2 | | 16 |
| 5 years | 9.2 | | 16 |
| 10 years | 9.2 | | 16 |
Monthly variations
Annual variations
| 2026 | -18.66% | ||
| 2025 | -10.60% |
- Stock Market
- Stocks
- ABT Stock
- ABL0 Stock
- Quotes Abbott Laboratories
Select your edition
All financial news and data tailored to specific country editions
